In autoradiograph studies (Gulyas et al., 2010) and radioligand binding studies of post-mortem tissues (Tejani-Butt et al., 1993), the norepinephrine transporter sites were significantly reduced in AD brains compared to normal control samples. The gene discussed is SLC6A2; the disease is Alzheimer disease.